Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon
- PMID: 19428077
- DOI: 10.1016/j.urology.2009.01.043
Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon
Abstract
Prostate brachytherapy is a commonly used modality for the treatment of prostate cancer. After prostate brachytherapy, the prostate-specific antigen (PSA) level may fluctuate and increase temporarily without a clear reason in 30-40% of successfully treated men. This phenomenon is called "PSA bounce" and engenders anxiety on the part of the patient and physician. Having reviewed the literature we found 19 articles and summarized in the current review to delineate the facts of this relatively common and ambiguous phenomenon. Although several patient and treatment related factors were assessed by studies, only age remained as the most consistent predictor.
Similar articles
-
Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.Radiother Oncol. 2008 Jul;88(1):102-7. doi: 10.1016/j.radonc.2008.04.004. Epub 2008 Apr 29. Radiother Oncol. 2008. PMID: 18453022
-
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.J Urol. 2003 Nov;170(5):1864-7. doi: 10.1097/01.ju.0000091644.41330.2a. J Urol. 2003. PMID: 14532794
-
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):512-7. doi: 10.1016/j.ijrobp.2005.07.960. Epub 2005 Oct 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16213667
-
[Prostate-specific antigen bounce after permanent seed prostate brachytherapy: a literature review].Cancer Radiother. 2012 Dec;16(8):702-10; quiz 722, 725. doi: 10.1016/j.canrad.2012.09.004. Epub 2012 Nov 22. Cancer Radiother. 2012. PMID: 23177779 Review. French.
-
[Elevation of PSA after prostate radiotherapy: rebound or biochemical recurrence?].Prog Urol. 2008 Oct;18(9):557-61. doi: 10.1016/j.purol.2008.06.001. Epub 2008 Jul 26. Prog Urol. 2008. PMID: 18986625 Review. French.
Cited by
-
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.Radiat Oncol. 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7. Radiat Oncol. 2020. PMID: 32460889 Free PMC article.
-
125I brachytherapy in younger prostate cancer patients : Outcomes in low- and intermediate-risk disease.Strahlenther Onkol. 2017 Sep;193(9):707-713. doi: 10.1007/s00066-017-1142-9. Epub 2017 May 9. Strahlenther Onkol. 2017. PMID: 28488030 English.
-
Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy.Br J Cancer. 2016 Jul 12;115(2):195-202. doi: 10.1038/bjc.2016.171. Br J Cancer. 2016. PMID: 27404586 Free PMC article.
-
Prostate-specific antigen bounce following stereotactic body radiation therapy for prostate cancer.Front Oncol. 2014 Jan 28;4:8. doi: 10.3389/fonc.2014.00008. eCollection 2014. Front Oncol. 2014. PMID: 24478988 Free PMC article.
-
Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer.Clin Med Insights Oncol. 2011;5:101-6. doi: 10.4137/CMO.S7073. Epub 2011 Apr 19. Clin Med Insights Oncol. 2011. PMID: 21603245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous